Dr. David T. Durack, (D Phil, FRCP, FRACP, FACP) is a Consulting Professor of Medicine at Duke University and was previously Senior Vice President, Corporate Medical Affairs, and Chief Medical Officer at Becton Dickinson & Co.
Dr. Durack has broad and deep expertise in the area of infectious diseases. He has performed extensive research on the pathogenesis and chemotherapy of bacterial and fungal infections, authoring his doctoral thesis entitled “Experimental Endocarditis” at Oxford University.
Earlier in his clinical career, Dr. Durack was a Chief Resident and faculty member in the Department of Medicine at the University of Washington, eventually becoming Chief of the Division of Infectious Diseases and International Health. Following his time at the University of Washington, Dr. Durack was a Professor of Medicine at Duke University. In addition to his clinical work, Dr. Durack has published more than 230 articles and textbook chapters and co-edited several textbooks.
Dr. Durack is a Fellow of the Royal College of Physicians (UK), the Royal Australasian College of Physicians, and the American College of Physicians. He has been elected to the American Society for Clinical Investigation, the Council of the Infectious Diseases Society of America, and the American Academy of Microbiology. He has served on an FDA Review Panel, the Joint Commission Resources Board of Directors, and as Chairman of the Board, ASM Resources. He is currently a Director for PixelEXX Systems Inc. and has 17 years of experience as a Medical Affairs functional leader and executive officer in the medical devices and diagnostics industry.
Dr. Durack attended the Correspondence School of West Australia and Scotch College. He earned his medical degree from the University of Western Australia and went on to Oxford University as a Rhodes Scholar where he completed his Doctor of Philosophy. Dr. Durack’s internship and residencies were conducted at Radcliffe Infirmary in Oxford and Royal Postgraduate Medical School at Hammersmith Hospital in London.